Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib
Article 2020 en
Authors
PE
Panagiotis Efentakis
HD
Hendrik Doerschmann
CW
Claudius Witzler
Abstract
1 min read
Carfilzomib induces a transient vascular impairment and oxidative burst. Cfz+Met increased vascular contractility and synergistically induced autophagy in all settings. Therefore, carfilzomib cannot be accredited for a permanent vascular dysfunction, while Cfz+Met exert vasoprotective potency.
Garyfallia Psarrakou, Michael Chatzistefanou, Panagiotis Efentakis, Aimilia Varela, Eleni‐Dimitra Papanagnou, Panagiota Nikolaou, Maria Tsoumani, Constantinos H. Davos, Efstathios Kastritis, Ioannis P. Trougakos, Meletios A Dimopoulos, Evangelos Terpos, Ioanna Andreadou
Discussion(0)
No comments yet. Be the first to comment.